title: A PET-compatible tissue bioreactor for research, discovery, and validation of imaging biomarkers and radiopharmaceuticals: system design and proof-of-concept studies.
abstract: Research and discovery of novel radiopharmaceuticals and targets thereof generally involves initial studies in cell cultures, followed by animal studies, both of which present several inherent limitations. The objective of this work was to develop a tissue bioreactor (TBR) enabling modulation of the microenvironment and to integrate the TBR with a small-animal PET scanner to facilitate imaging biomarker research and discovery and validation of radiopharmaceuticals.
  
  
  METHODS
  The TBR chamber is a custom-blown, water-jacketed, glass vessel enclosed in a circulating perfusion bath powered by a peristaltic pump, which is integrated within the field of view of the PET scanner. The chamber is in series with a gas exchanger and a vessel for degassing the system during filling. Dissolved oxygen/temperature probes and septa for injection or sampling are located at the inlet and outlet of the cell chamber. A pH probe is located at the chamber outlet. Effluent is collected in the fraction collector as mixed-cup samples. In addition, both medium and tissue chamber can be sampled to investigate tissue and secretory products through multiscale analysis. As a proof of concept, we studied the effects of lipids on glucose uptake using HepG2 cells. To that end, we varied the nutrient substrate environment over a period of approximately 27 d, before and after the addition of lipids, and studied the effects of pioglitazone, a peroxisome proliferator-activated receptor γ agonist, on lipid and glucose uptake. In parallel, the TBR was imaged by PET in conjunction with (11)C-palmitate in the presence and absence of lipids to characterize (11)C-palmitate uptake.
  
  
  RESULTS
  The O2 consumption, glucose consumption, lactate production, and free fatty acid consumption and production rates were consistent in demonstrating the effects of lipids on glucose uptake. Pioglitazone exhibited improved glucose uptake within 3 d of treatment. Semiquantitative analysis suggested that lipids induced greater (11)C-palmitate uptake.
  
  
  CONCLUSIONS
  The integrated TBR offers a platform to monitor and modulate the tissue microenvironment, thus facilitating tissue-specific imaging and therapeutic biomarkers of disease, identification of molecular diagnostic markers, and validation of radiopharmaceuticals in both rodent and human cell lines.
authors: Department of Radiology, Washington University in St. Louis, St. Louis, Missouri.
authors: Timothy D
authors: TD
authors: Whitehead
authors: Samuel T
authors: ST
authors: Nemanich
authors: Carmen
authors: C
authors: Dence
authors: Kooresh I
authors: KI
authors: Shoghi
mesh_terms: D001692:Biological Transport / Q000187:drug effects; D015415:Biomarkers / Q000378:metabolism; D019149:Bioreactors; D004305:Dose-Response Relationship, Drug; D055808:Drug Discovery; D004867:Equipment Design; D005240:Feasibility Studies; D005947:Glucose / Q000378:metabolism; D056945:Hep G2 Cells; D006801:Humans; D008055:Lipids / Q000494:pharmacology; D010168:Palmitates / Q000378:metabolism; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012106:Research
chemical_list: D015415:Biomarkers; D008055:Lipids; D010168:Palmitates; D019275:Radiopharmaceuticals; D005947:Glucose
keywords: biomarker discovery; bioreactor; imaging; positron emission tomography (PET); tissue engineering
references: Anticancer Res. 2008 Nov-Dec;28(6A):3593-9
references: 19189639
references: J Nucl Med. 2006 Jun;47(6):999-1006
references: 16741310
references: J Huazhong Univ Sci Technolog Med Sci. 2011 Apr;31(2):185-189
references: 21505982
references: Inflammation. 2011 Dec;34(6):659-67
references: 21110076
references: PPAR Res. 2012;2012:968040
references: 23213321
references: Curr Opin Genet Dev. 2008 Feb;18(1):27-34
references: 18282701
references: Methods Enzymol. 2004;385:286-315
references: 15130745
references: J Biosci Bioeng. 2005 Sep;100(3):235-45
references: 16243271
references: Trends Biotechnol. 2004 Feb;22(2):80-6
references: 14757042
references: Curr Opin Lipidol. 2009 Dec;20(6):477-83
references: 19779336
references: J Clin Pharmacol. 2005 Oct;45(10):1137-44
references: 16172178
references: J Biol Chem. 2010 Sep 24;285(39):29965-73
references: 20647313
references: Trends Genet. 2009 Jan;25(1):30-8
references: 19054589
references: Mol Cell Proteomics. 2010 Jun;9(6):1085-99
references: 20124223
references: Metabolism. 2010 Jul;59(7):927-34
references: 20006364
references: Breast Cancer Res. 2008;10(1):202
references: 18304378
references: Ann Oncol. 2011 Dec;22(12):2640-2645
references: 21415239
references: Exp Mol Pathol. 2011 Dec;91(3):768-74
references: 21930124
references: Lancet Oncol. 2004 Jul;5(7):419-29
references: 15231248
references: Biotechnol Prog. 2007 Nov-Dec;23(6):1485-91
references: 17958443
references: Ann Oncol. 2012 Jul;23(7):1771-80
references: 22112968
references: J Cell Mol Med. 2008 Jan-Feb;12(1):56-66
references: 18021311
references: Anesth Analg. 2001 Jul;93(1):121-7
references: 11429352
references: Nat Rev Mol Cell Biol. 2007 Oct;8(10):839-45
references: 17684528
references: Nat Methods. 2007 Apr;4(4):359-65
references: 17396127
references: Anesthesiology. 1990 Jul;73(1):82-92
references: 2360744
references: Clin Chim Acta. 1962 Mar;7:206-11
references: 13899279
references: Biol Pharm Bull. 2011;34(10):1613-8
references: 21963504
references: Osteoarthritis Cartilage. 2002 Jan;10(1):62-70
references: 11795984
references: Mol Cell Biochem. 1983;53-54(1-2):35-56
references: 6621517
references: PPAR Res. 2008;2008:314974
references: 18528521